ImportRefusal LogoImportRefusal

Lyka Bdr International Ltd

⚠️ High Risk

FEI: 3007522260 • Mumbai • INDIA

FEI

FEI Number

3007522260

📍

Location

Mumbai

🇮🇳

Country

INDIA
🏢

Address

Gate No 3, Unit No. 101, , Mumbai, , India

High Risk

FDA Import Risk Assessment

56.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

51
Total Refusals
4
Unique Violations
3/6/2017
Latest Refusal
4/28/2009
Earliest Refusal

Score Breakdown

Violation Severity
76.7×40%
Refusal Volume
63.6×30%
Recency
0.0×20%
Frequency
64.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7544×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11820×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
3/6/2017
62CCL10CLONIDINE HCL (ANTI-HYPERTENSIVE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/8/2017
61MCL24PHENYTOIN SODIUM (ANTI-CONVULSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/6/2017
64PCL04TRANEXAMIC ACID (HEMOSTATIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/20/2017
62CCL10CLONIDINE HCL (ANTI-HYPERTENSIVE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/20/2017
64LCR41HYDROCORTISONE SODIUM SUCCINATE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/20/2017
61MCL24PHENYTOIN SODIUM (ANTI-CONVULSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/7/2015
60LCA69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
10/7/2015
56BBB03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Florida District Office (FLA-DO)
10/7/2015
62GAA46KETOPROFEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Florida District Office (FLA-DO)
9/10/2015
64LCA41HYDROCORTISONE SODIUM SUCCINATE (GLUCOCORTICOID)
75UNAPPROVED
Florida District Office (FLA-DO)
9/10/2015
61JAA14SIMVASTATIN (ANTI-CHOLESTEREMIC)
75UNAPPROVED
Florida District Office (FLA-DO)
9/10/2015
60SAB25RANITIDINE HYDROCHLORIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
6/8/2015
61FAE53CEFADROXIL MONOHYDRATE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/25/2014
62KAE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/25/2014
61LAA38CLOPIDOGREL BISULFATE (ANTI-COAGULANT)
75UNAPPROVED
Florida District Office (FLA-DO)
7/1/2014
62KAE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/14/2014
62KAE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/10/2014
62KAE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
118NOT LISTED
3280FRNMFGREG
Florida District Office (FLA-DO)
2/19/2014
64UBB04CILASTATIN SODIUM/IMIPENEM (INHIBITOR (DECARBOXYLASE))
75UNAPPROVED
Florida District Office (FLA-DO)
6/25/2013
64LCA41HYDROCORTISONE SODIUM SUCCINATE (GLUCOCORTICOID)
118NOT LISTED
75UNAPPROVED
Florida District Office (FLA-DO)
6/25/2013
64LCA41HYDROCORTISONE SODIUM SUCCINATE (GLUCOCORTICOID)
118NOT LISTED
75UNAPPROVED
Florida District Office (FLA-DO)
6/25/2013
64LCA41HYDROCORTISONE SODIUM SUCCINATE (GLUCOCORTICOID)
118NOT LISTED
75UNAPPROVED
Florida District Office (FLA-DO)
5/23/2013
64LCA41HYDROCORTISONE SODIUM SUCCINATE (GLUCOCORTICOID)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Florida District Office (FLA-DO)
4/15/2013
62GAA46KETOPROFEN (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/9/2013
60LCA69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/12/2012
56BBB03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/21/2012
60LCL99ANALGESIC, N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/21/2012
65PAA02SILDENAFIL CITRATE (REGULATOR)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/21/2012
62KAE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/6/2012
56JAA22CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/3/2012
61FAE53CEFADROXIL MONOHYDRATE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/28/2012
60LCL99ANALGESIC, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/30/2012
65PAA02SILDENAFIL CITRATE (REGULATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/4/2011
65PAA02SILDENAFIL CITRATE (REGULATOR)
118NOT LISTED
75UNAPPROVED
Florida District Office (FLA-DO)
10/4/2011
62GCB94KETOROLAC TROMETHAMINE (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Florida District Office (FLA-DO)
10/4/2011
61JAA14SIMVASTATIN (ANTI-CHOLESTEREMIC)
118NOT LISTED
75UNAPPROVED
Florida District Office (FLA-DO)
4/20/2011
64UAL04CILASTATIN SODIUM/IMIPENEM (INHIBITOR (DECARBOXYLASE))
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/4/2011
60LCL99ANALGESIC, N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
4/4/2011
61GCL80MEROPENEM (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
2/9/2011
56JCK22CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/10/2011
56JAA22CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
118NOT LISTED
Division of Southeast Imports (DSEI)
1/10/2011
56JAA22CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
118NOT LISTED
Division of Southeast Imports (DSEI)
1/10/2011
56JAA22CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
118NOT LISTED
Division of Southeast Imports (DSEI)
12/21/2010
56JAA99LINCOMYCIN N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/3/2010
61GCL80MEROPENEM (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/26/2010
61GCL80MEROPENEM (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
75UNAPPROVED
Florida District Office (FLA-DO)
4/26/2010
61GCL80MEROPENEM (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
75UNAPPROVED
Florida District Office (FLA-DO)
5/14/2009
60LCL99ANALGESIC, N.E.C.
75UNAPPROVED
Florida District Office (FLA-DO)
5/14/2009
62VCA18ACYCLOVIR (ANTI-VIRAL)
75UNAPPROVED
Florida District Office (FLA-DO)
5/13/2009
61GCL80MEROPENEM (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
27DRUG GMPS
Division of Southeast Imports (DSEI)
4/28/2009
64UDL04CILASTATIN SODIUM/IMIPENEM (INHIBITOR (DECARBOXYLASE))
75UNAPPROVED
Florida District Office (FLA-DO)

Frequently Asked Questions

What is Lyka Bdr International Ltd's FDA import refusal history?

Lyka Bdr International Ltd (FEI: 3007522260) has 51 FDA import refusal record(s) in our database, spanning from 4/28/2009 to 3/6/2017.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lyka Bdr International Ltd's FEI number is 3007522260.

What types of violations has Lyka Bdr International Ltd received?

Lyka Bdr International Ltd has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Lyka Bdr International Ltd come from?

All FDA import refusal data for Lyka Bdr International Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.